2020-2021 / PHIN2004-1

Active substances

Substances emerging from pharmacochemical research, part a

Substances emerging from pharmacochemical research, part b

Substances emerging from biotechnology

Substances of natural origin, part a

Substances of natural origin, part b

Radiopharmaceuticals products

Duration

Substances emerging from pharmacochemical research, part a : 10h Th
Substances emerging from pharmacochemical research, part b : 5h Th
Substances emerging from biotechnology : 15h Th
Substances of natural origin, part a : 5h Th
Substances of natural origin, part b : 5h Th
Radiopharmaceuticals products : 10h Th

Number of credits

 Specialised master in industrial pharmacy6 crédits 

Lecturer

Substances emerging from pharmacochemical research, part a : Bernard Pirotte
Substances emerging from pharmacochemical research, part b : François Dufrasne
Substances emerging from biotechnology : David Vermijlen
Substances of natural origin, part a : Joëlle Leclercq
Substances of natural origin, part b : Caroline Stevigny
Radiopharmaceuticals products : Zena Wimana

Coordinator

Philippe Hubert

Language(s) of instruction

French language

Organisation and examination

All year long, with partial in January

Schedule

Schedule online

Units courses prerequisite and corequisite

Prerequisite or corequisite units are presented within each program

Learning unit contents

Substances emerging from pharmacochemical research, part a

The course comprises two parts. The first part is devoted to the presentation of the main strategies used to discover new drugs at the level of the pharmaceutical industry (use of biological informations, systematic screening, improvement of existing drugs, rational drug design). The second part is dedicated to the presentation of concrete examples of drug discovery (more specifically drugs resulting from Industry-University collaborations).

Learning outcomes of the learning unit

Substances emerging from pharmacochemical research, part a

To familiarize the student with the strategies used by the pharmaceutical industry to discover new drugs (new chemical entities).

Prerequisite knowledge and skills

Substances emerging from pharmacochemical research, part a

University degree of pharmacist

Planned learning activities and teaching methods

Substances emerging from pharmacochemical research, part a

None

Mode of delivery (face to face, distance learning, hybrid learning)

Organisational adjustments related to the current health context

Substances emerging from pharmacochemical research, part a

According to the evolution of the health situation, live courses could be replaced by online courses.
Likewise, the oral live examination could be replaced by an oral online examination.

Recommended or required readings

Substances emerging from pharmacochemical research, part a

Written notes are distributed each year to the students.

Assessment methods and criteria

Below you will find information on the evaluation methods planned for in-person and remote exams as well as those planned for hybrid sessions. Depending on how the health crisis evolves, the chosen method will be communicated to you no later than one month before the start of the exam session.

Substances emerging from pharmacochemical research, part a

Any session :

- In-person

oral exam

- Remote

oral exam

- If evaluation in "hybrid"

preferred in-person


Additional information:

Oral examination comprising the presentation of a scientific article received before the examination followed by an interrogation on theoretical aspects of the course.

Work placement(s)

Organizational remarks

Contacts

Substances emerging from pharmacochemical research, part a

Professeur Bernard PIROTTE Laboratoire de Chimie Pharmaceutique Quartier Hôpital, 15, Avenue Hippocrate, B-4000 Liège C.H.U. - tour 4 - niveau + 5 (Bât. B36) tel : 04 366 43 65 - fax : 04 366 43 62 e-mail: B.Pirotte@uliege.be  Secrétariat : Mme Annabelle HAMANDE (tel : 04 366 43 61)